Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014

被引:52
作者
Horvat, Natally [1 ,2 ]
Nikolovski, Ines [1 ]
Long, Niamh [1 ]
Gerst, Scott [1 ]
Zheng, Jian [3 ]
Pak, Linda Ma [3 ]
Simpson, Amber [3 ]
Zheng, Junting [4 ]
Capanu, Marinela [4 ]
Jarnagin, William R. [3 ]
Mannelli, Lorenzo [1 ]
Do, Richard Kinh Gian [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10065 USA
[2] Hosp Sirio Libanes, Dept Radiol, Sao Paulo, Brazil
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
Liver neoplasms; Hepatocellular carcinoma; Magnetic resonance imaging; Cholangiocarcinoma; Intrahepatic cholangiocarcinoma; ENHANCEMENT PATTERNS; CLINICAL-FEATURES; CANCER STATISTICS; CT; TRANSPLANTATION;
D O I
10.1007/s00261-017-1261-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the prevalence of major and ancillary imaging features from liver imaging reporting and data systems (LI-RADS) version 2014 and their interreader agreement when comparing hepatocellular carcinoma (HCC) to intrahepatic cholangiocarcinoma (ICC) and combined tumor (cHCC-CC). Methods: The Institutional Review Board approved this HIPAA-compliant retrospective study and waived the requirement for patients' informed consent. Patients with resected HCC (n = 51), ICC (n = 40), and cHCC-CC (n = 11) and available pre-operative contrast-enhanced MRI were included from 2000 to 2015. Imaging features and final LI-RADS category were evaluated by four radiologists. Imaging features were compared by Fisher's exact test and interreader agreements were assessed by kappa statistics. Results: None of the features were unique to either HCC or non-HCC. Imaging features that were significantly more common among HCC compared to ICC and cHCC-CC included washout (76%-78% vs. 10%-35%, p < 0.001), capsule (55%-71% vs. 16%-49%, p < 0.05), and intralesional fat (27%-52% vs. 2%-12%, p < 0.002). Features that were more common among ICC and cHCC-CC included peripheral arterial phase hyperenhancement (40%-64% vs. 10%-14%, p < 0.001) and progressive central enhancement (65%-82% vs. 14%-25%, p < 0.001). The interreader agreement was moderate for each of these imaging features (kappa = 0.41-0.55). Moderate agreement was also achieved in the assignment of LR-M (kappa = 0.53), with an overall sensitivity and specificity for non-HCC malignancy of 86.3% and 78.4%, respectively. Conclusion: HCC and non-HCC show significant differences in the prevalence of imaging features defined by LI-RADS, and are identified by radiologists with moderate interreader agreement. Using LI-RADS, radiologists also achieved moderate interreader agreement in the assignment of the LR-M category.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 27 条
[21]  
Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI [10.3322/caac.21654, 10.3322/caac.20006, 10.3322/caac.21332, 10.3322/caac.21254, 10.3322/caac.21601, 10.3322/caac.20073, 10.3322/caac.21387, 10.3322/caac.21551]
[22]   Postoperative Imaging in Liver Transplantation: What Radiologists Should Know [J].
Singh, Ajay K. ;
Nachiappan, Arun C. ;
Verma, Hetal A. ;
Uppot, Raul N. ;
Blake, Michael A. ;
Saini, Sanjay ;
Boland, Giles W. .
RADIOGRAPHICS, 2010, 30 (02) :339-351
[23]   Global Cancer Statistics, 2012 [J].
Torre, Lindsey A. ;
Bray, Freddie ;
Siegel, Rebecca L. ;
Ferlay, Jacques ;
Lortet-Tieulent, Joannie ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2015, 65 (02) :87-108
[24]  
Valverde A, 1999, J Hepatobiliary Pancreat Surg, V6, P122, DOI 10.1007/s005340050094
[25]   Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers [J].
Xu, Jing ;
Igarashi, Saya ;
Sasaki, Motoko ;
Matsubara, Takashi ;
Yoneda, Norihide ;
Kozaka, Kazuto ;
Ikeda, Hiroko ;
Kim, Jihun ;
Yu, Eunsil ;
Matsui, Osamu ;
Nakanuma, Yasuni .
LIVER INTERNATIONAL, 2012, 32 (07) :1156-1164
[26]   Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and Prognosis [J].
Yin, Xin ;
Zhang, Bo-Heng ;
Qiu, Shuang-Jian ;
Ren, Zheng-Gang ;
Zhou, Jian ;
Chen, Xiao-Hong ;
Zhou, Ying ;
Fan, Jia .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) :2869-2876
[27]   Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma [J].
Zheng, Jian ;
Kuk, Deborah ;
Goenen, Mithat ;
Balachandran, Vinod P. ;
Kingham, T. Peter ;
Allen, Peter J. ;
D'Angelica, Michael I. ;
Jarnagin, William R. ;
DeMatteo, Ronald P. .
ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (05) :1358-1366